Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)

Market Cap	3.92B
Revenue (ttm)	3.65B
Net Income (ttm)	386.00M
Shares Out	19.00M
EPS (ttm)	20.14
PE Ratio	10.39
Forward PE	n/a
Dividend	2.00 (0.97%)
Ex-Dividend Date	Aug 9, 2024

Volume	21,576
Average Volume	43,606
Open	208.67
Previous Close	206.36
Day's Range	205.75 - 210.32
52-Week Range	137.55 - 264.31
Beta	0.44
RSI	62.25
Earnings Date	Jul 23, 2025

About Nath Bio-Genes (India)

Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; fruit seeds; and seeds for vegetables comprising chilli, onion, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, sweet pepper, green peas, pumpkin,...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 1979
• Employees: 423
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: NATHBIOGEN

Financial Performance

In 2024, Nath Bio-Genes (India)'s revenue was 3.65 billion, an increase of 9.66% compared to the previous year's 3.33 billion. Earnings were 386.00 million, a decrease of -2.57%.